MDGL
Madrigal Pharmaceuticals Inc
518.80$
-0.6%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -100.0% | – | – | – | – | – | – | +432.1% | |
| – | -100.0% | – | +49,259.0% | +24.7% | +16.7% | +320.5% | -14.0% | +15.3% | +12.8% | +1,082.7% | +800.8% | |
| – | – | – | – | -127.4% | – | – | – | – | – | – | +418.8% | |
| – | -20.5% | -70.6% | +53.1% | +4.1% | +184.9% | +155.5% | +11.0% | +19.6% | +11.0% | -13.1% | +64.1% | |
| – | -14.9% | -30.6% | -17.4% | +99.3% | +48.1% | -3.5% | +70.7% | +29.0% | +124.7% | +302.3% | +87.1% | |
| – | -96.2% | +695.5% | +27.1% | +26.9% | +133.4% | +117.6% | +17.3% | +21.1% | +29.6% | +76.6% | +79.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -52.0% | +9.7% | -52.1% | +1,274.7% | +43.7% | -60.7% | -76.0% | +280.8% | +220.7% | +15.4% | +52.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -241.5% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.